Sharjah Institute for Medical Research, University of Sharjah, Sharjah 27272, United Arab Emirates.
Sharjah Institute for Medical Research, University of Sharjah, Sharjah 27272, United Arab Emirates; Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates; Faculty of Pharmacy, University of Mansoura, Mansoura 35516, Egypt.
Bioorg Med Chem. 2019 Sep 1;27(17):3889-3901. doi: 10.1016/j.bmc.2019.07.026. Epub 2019 Jul 13.
In the current work, we report the discovery of new sulfonate and sulfamate derivatives of benzofuran- and benzothiophene as potent inhibitors of human carbonic anhydrases (hCAs) II, IX and XII. A set of derivatives, 1a-t, having different substituents on the fused benzofuran and benzothiophene rings (R = alkyl, cyclohexyl, aryl, NH, NHMe, or NMe) was designed and synthesized. Most of the derivatives exhibited higher potency than acetazolamide as inhibitors of the purified hCAII, IX and XII isoforms. The most potent inhibitors for hCAII, hCAIX and hCAXII were 1g, 1b and 1d with an IC ± SEM values of 0.14 ± 0.03, 0.13 ± 0.03 and 0.17 ± 0.06 µM, respectively. In addition, compounds 1d and 1n exerted preferential inhibitory effect against hCAXII isozyme with good potencies. Some selected compounds were docked within the active pocket of these isozymes and binding of the molecules revealed that sulfonate and sulfamate rings were located towards the active cavity and compounds coordinated to zinc ions.
在目前的工作中,我们报道了苯并呋喃和苯并噻吩的新磺酸盐和磺酰胺衍生物作为人碳酸酐酶(hCA)II、IX 和 XII 的有效抑制剂的发现。设计并合成了一组在稠合的苯并呋喃和苯并噻吩环上具有不同取代基的衍生物 1a-t(R=烷基、环己基、芳基、NH、NHMe 或 NMe)。大多数衍生物作为纯化的 hCAII、IX 和 XII 同工酶的抑制剂显示出比乙酰唑胺更高的活性。对 hCAII、hCAIX 和 hCAXII 具有最强抑制活性的抑制剂分别为 1g、1b 和 1d,IC50±SEM 值分别为 0.14±0.03、0.13±0.03 和 0.17±0.06 µM。此外,化合物 1d 和 1n 对 hCAXII 同工酶表现出优先抑制作用,具有良好的活性。选择了一些化合物进行对接,这些化合物位于这些同工酶的活性口袋内,分子的结合表明磺酸盐和磺酰胺环位于活性腔中,化合物与锌离子配位。